ASCLS eNewsBytes

• How do hormonal IUDs affect breast cancer risk? October 28, 2024
  A Danish Cancer Society Research Center study has found an association between levonorgestrel-releasing intrauterine systems and increased breast cancer risk in females aged 15 to 49, compared to those who did not use hormonal IUDs.
• FDA grants IND clearance for RiboX's RXRG001 October 28, 2024
  The U.S. FDA has approved RiboX Therapeutics' investigational new drug application for a Phase I/IIa clinical trial of RXRG001, a circular RNA therapy designed to treat radiation induced xerostomia and hyposalivation in head and neck cancer patients.
• Study: Sudden decrease in hospitalization rates were seen at start of COVID-19 pandemic October 28, 2024
  A study by Dialysis Clinic Inc. found that all-cause mortality decreased by 15.4% from 2018 to 2023, with a sharp increase in mortality in March 2020. The study also found that the availability of COVD-19 vaccines led to a marked decline in mortality by early 2021.
• Marburg virus disease October 28, 2024
  Marburg virus disease is a severe, often fatal illness in humans, with an average case fatality rate of around 50%. The disease is caused by the Marburg virus and Ravn virus, which spreads through human-to-human transmission.
• Many deaths attributed to natural causes during the COVID-19 pandemic may have instead been due to the virus October 28, 2024
  A study by scientists from the University of Pennsylvania and Boston University found that COVID-19-related disruptions in health care and society may have contributed to the 1.2 million more deaths than expected in the U.S. between March 2020 and August 2022.